Attend events and get industry leading knowledge and information by the experts at PLL.
Many innovative combinations of pharmaceuticals, biologics and medical devices across a broad range of therapeutic areas are being developed to meet unmet medical needs. While single entity combination products have exciting potential, they also present unique challenges in development and approval. One of these challenges is the development and validation of analytical methods to assess the quality, safety and stability of the single entity combination product. In this presentation analytical testing strategies will be discussed to address the unique challenges presented by single entity combination devices.